147 related articles for article (PubMed ID: 37694309)
1. Addressing the "Replication Crisis" in the Field of Parkinson's Disease.
Albanese F; Bloem BR; Kalia LV
J Parkinsons Dis; 2023; 13(6):849-850. PubMed ID: 37694309
[No Abstract] [Full Text] [Related]
2. [Akinetic crisis in Parkinson disease].
Bächli E; Albani C
Schweiz Med Wochenschr; 1994 Jun; 124(23):1017-23. PubMed ID: 8023100
[TBL] [Abstract][Full Text] [Related]
3. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease.
Chaudhuri KR; Pal S; DiMarco A; Whately-Smith C; Bridgman K; Mathew R; Pezzela FR; Forbes A; Högl B; Trenkwalder C
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):629-35. PubMed ID: 12438461
[TBL] [Abstract][Full Text] [Related]
4. [Anaesthesia and Perioperative Management for Patients with Parkinson's Disease].
Zech N; Sinner B
Anasthesiol Intensivmed Notfallmed Schmerzther; 2022 Sep; 57(9):578-586. PubMed ID: 36049741
[TBL] [Abstract][Full Text] [Related]
5. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.
Peto V; Jenkinson C; Fitzpatrick R; Greenhall R
Qual Life Res; 1995 Jun; 4(3):241-8. PubMed ID: 7613534
[TBL] [Abstract][Full Text] [Related]
6. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
[TBL] [Abstract][Full Text] [Related]
7. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
[TBL] [Abstract][Full Text] [Related]
8. [Problem solving care models for Parkinson's disease].
Csóka M; Molnár S; Kellős É; Domján G
Orv Hetil; 2016 May; 157(22):855-68. PubMed ID: 27211355
[TBL] [Abstract][Full Text] [Related]
9. Measuring the impact of Parkinson's disease: an occupational therapy perspective.
Gaudet P
Can J Occup Ther; 2002 Apr; 69(2):104-13. PubMed ID: 11977869
[TBL] [Abstract][Full Text] [Related]
10. The Causes and Impact of Crisis for People with Parkinson's Disease: A Patient and Carer Perspective.
Fearn S; Bartolomeu Pires S; Agarwal V; Roberts HC; Spreadbury J; Kipps C
J Parkinsons Dis; 2021; 11(4):1935-1945. PubMed ID: 34250952
[TBL] [Abstract][Full Text] [Related]
11. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
[TBL] [Abstract][Full Text] [Related]
12. An overview of sleep and circadian dysfunction in Parkinson's disease.
Mantovani S; Smith SS; Gordon R; O'Sullivan JD
J Sleep Res; 2018 Jun; 27(3):e12673. PubMed ID: 29493044
[TBL] [Abstract][Full Text] [Related]
13. Using the Gene Ontology to Annotate Key Players in Parkinson's Disease.
Foulger RE; Denny P; Hardy J; Martin MJ; Sawford T; Lovering RC
Neuroinformatics; 2016 Jul; 14(3):297-304. PubMed ID: 26825309
[TBL] [Abstract][Full Text] [Related]
14. Terminal Choking in Parkinson's Disease.
Ling A; Herbert F; Wright B; Richfield E
J Pain Symptom Manage; 2022 Jun; 63(6):e757-e764. PubMed ID: 35081446
[No Abstract] [Full Text] [Related]
15. Translation, Adaptation and Validation of the European Portuguese Version of the NMS-Quest for Parkinson's Disease.
Pedro T; Moreira F; Silva A
Acta Med Port; 2021 Jan; 34(1):6-11. PubMed ID: 32716283
[TBL] [Abstract][Full Text] [Related]
16. The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension.
Pavy-Le Traon A; Amarenco G; Duerr S; Kaufmann H; Lahrmann H; Shaftman SR; Tison F; Wenning GK; Goetz CG; Poewe W; Sampaio C; Schrag A; Stebbins GT; Rascol O
Mov Disord; 2011 Sep; 26(11):1985-92. PubMed ID: 21547951
[TBL] [Abstract][Full Text] [Related]
17. Minor depression and brain perfusion images in Parkinson's disease.
Matsui H; Nishinaka K; Oda M; Komatsu K; Kubori T; Udaka F
Mov Disord; 2006 Aug; 21(8):1169-74. PubMed ID: 16685687
[TBL] [Abstract][Full Text] [Related]
18. Apathy in Parkinson's disease.
Pluck GC; Brown RG
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):636-42. PubMed ID: 12438462
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced Parkinson's disease.
Giugni JC; Okun MS
Curr Opin Neurol; 2014 Aug; 27(4):450-60. PubMed ID: 24978634
[TBL] [Abstract][Full Text] [Related]
20. LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients.
Atashrazm F; Hammond D; Perera G; Bolliger MF; Matar E; Halliday GM; Schüle B; Lewis SJG; Nichols RJ; Dzamko N
Mov Disord; 2019 Mar; 34(3):406-415. PubMed ID: 30597610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
